IBRX Lawsuit Alleges Company Allegedly Violated Drug Promotion Laws - ImmunityBio Investors Face Losses Following Company Allegedly Violated Drug Promotion Laws: Hagens Berman

Likely AI

www.globenewswire.comby Hagens Berman Sobol Shapiro LLPMay 8, 2026Submitted May 8, 2026

SAN FRANCISCO, May 08, 2026 (GLOBE NEWSWIRE) -- ImmunityBio, Inc. (NASDAQ: IBRX) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired ImmunityBio...

The Verdict

ClassificationLikely AI

ConfidenceHigh confidence

Analyzedtext, image

ImageAI Generated

Community Verdict

Be the first to vote on this assessment.

Embed Badge

Add this badge to your site to show the AI classification for this content.

[![Real Press](https://real.press/api/badge/96f3ce85-d98e-4efa-8e84-04463c781d0b)](https://real.press/content/96f3ce85-d98e-4efa-8e84-04463c781d0b)